Lipid Metabolic Reprogramming in Periodontitis-Associated Alveolar Bone Remodeling: Mechanisms, Signaling Pathways, and Therapeutic Implications
Biomolecules · 14.09.2026 · 16 (9) · 1334
DOI: 10.3390/biom16091334 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 14.09.2026. Verfasst von Jinping Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. Hauptthemen laut MEDLINE: Periodontitis, Lipid Metabolism, Bone Remodeling, Alveolar Bone Loss. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Periodontitis-associated alveolar bone loss reflects not only persistent inflammation but also profound metabolic remodeling within the periodontal microenvironment. This review synthesizes current evidence on how lipid metabolic reprogramming regulates periodontal bone remodeling and its therapeutic significance. Under physiological conditions, fatty acid uptake and β-oxidation, lipid droplet turnover, and lipid-derived signaling support osteoblast bioenergetics, stem-cell osteogenesis, and balanced bone remodeling. In contrast, dyslipidemia and chronic inflammatory stress promote the accumulation of free fatty acids, oxidized lipoproteins, cholesterol derivatives, and sphingolipid metabolites, thereby enhancing reactive oxygen species production, lipid peroxidation, inflammasome activation, and pro-inflammatory immune polarization. These changes suppress osteogenic differentiation, stimulate osteoclastogenesis, and impair periodontal regeneration. We further integrate major regulatory networks, including PPARγ–Wnt/β-catenin, AMPK–mTOR, NF-κB/NLRP3, and GSK3β–NRF2/ferroptosis signaling. Therapeutic strategies targeting these lipid–redox–immune circuits include specialized pro-resolving lipid mediators, n-3 polyunsaturated fatty acids, statins, metabolic modulators, and local biomaterial- or nanocarrier-based delivery systems. Accordingly, lipid metabolic reprogramming may provide a framework for developing metabolism-oriented adjunctive and regenerative strategies for periodontitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Stomatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
- School of Stomatology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
- Hubei Province Key Laboratory of Oral and Maxillofacial Development and Regeneration, Wuhan 430030, China.
Förderung
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Wang, J., Zhang, X., Zhang, Y., Wang, X., Yang, B., Hu, X., Mao, J., Zhang, Z., & Li, H. (2026). Lipid Metabolic Reprogramming in Periodontitis-Associated Alveolar Bone Remodeling: Mechanisms, Signaling Pathways, and Therapeutic Implications. Biomolecules, 16(9), 1334. https://doi.org/10.3390/biom16091334
Vancouver
Wang J, Zhang X, Zhang Y, Wang X, Yang B, Hu X, et al. Lipid Metabolic Reprogramming in Periodontitis-Associated Alveolar Bone Remodeling: Mechanisms, Signaling Pathways, and Therapeutic Implications. Biomolecules. 2026;16(9):1334. doi:10.3390/biom16091334
BibTeX
@article{Wang2026,
author = {Wang, Jinping and Zhang, Xiaorui and Zhang, Yuxiao and Wang, Xiangyao and Yang, Bowen and Hu, Xiaojie and Mao, Jing and Zhang, Zhixing and Li, Haosen},
title = {Lipid Metabolic Reprogramming in Periodontitis-Associated Alveolar Bone Remodeling: Mechanisms, Signaling Pathways, and Therapeutic Implications},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {9},
pages = {1334},
doi = {10.3390/biom16091334}
}
EUVIMED